Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: the Chief who wrote (1114)	3/18/1998 11:17:00 AM
From: Moses	Read Replies (1) \| Respond to of 8117

So, what do you think a 17 year patent on the cutting-edge of technology is worth? We have a proven elixir. This technology has the potential to save your life. What a great investment.

To: the Chief who wrote (1114)	3/18/1998 12:06:00 PM
From: T Lamos	Read Replies (1) \| Respond to of 8117

Price Forming Base & Resistance Levels To all. For the second day in a row we have observed resistance at the $5.20 mark. At the same time the share price is stabilizing at around the $5.50 level now that the massive price runup of the past few weeks appears over - at least for now - as the market forms a new base for PYNG. Thanks to the chief, others and Canada Stockwatch for providing the necessary data used to reach these best educated "guesstimates" of how market activity and positive investor sentiment is shaping the valuation. Bought in again this morning at $5.25, putting up more money in support of my conclusions and faith in this sure-fire company. I would encourage those who haven't carefully read the news releases at www.pyng.com to do so. Product is now hitting the market with sales volumes building as PYNG provides units in support of field trials. And remember that many other Emergency Medical Services units across the continent are lining up with the intent to start ordering and using the product immediately as soon as the field trial reports are published. These statements are facts not rumours. Do your due diligence! Last but not least, let's not forget that the rest of the world is also knocking at the company's door too. If you don't believe me, read the news release regarding last week's medical conference which states that many international representatives attended the conference mainly to find out more about FAST1. Bottom line - get in on PYT while you can at these bargain basement levels. I'm in for the long haul and am expecting a ten-fold return on investment over the next two years. Good luck to all. Tom